{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:46:46Z","timestamp":1784882806358,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["KL2 TR002379"],"award-info":[{"award-number":["KL2 TR002379"]}],"id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.mayocp.2019.10.007","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T20:25:36Z","timestamp":1581539136000},"page":"1253-1267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["A Practical Approach for the Management of the Mixed Opioid Agonist-Antagonist Buprenorphine During Acute Pain and Surgery"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6435-368X","authenticated-orcid":false,"given":"Nafisseh S.","family":"Warner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6625-8755","authenticated-orcid":false,"given":"Matthew A.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8368-1590","authenticated-orcid":false,"given":"Halena M.","family":"Gazelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5645-6355","authenticated-orcid":false,"given":"W. Michael","family":"Hooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6627-2410","authenticated-orcid":false,"given":"Bhanu Prakash","family":"Kolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0365-2536","authenticated-orcid":false,"given":"David O.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.mayocp.2019.10.007_bib1","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mayocp.2019.10.007_bib2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/pm\/pny307","article-title":"Challenges with implementing the Centers for Disease Control and Prevention Opioid Guideline: a consensus panel report","volume":"20","author":"Kroenke","year":"2019","journal-title":"Pain Med"},{"issue":"5","key":"10.1016\/j.mayocp.2019.10.007_bib3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.mayocp.2019.10.007_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jat\/20.6.369","article-title":"Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine","volume":"20","author":"Kuhlman","year":"1996","journal-title":"J\u00a0Anal Toxicol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.10.007_bib5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/bja\/57.2.192","article-title":"Clinical actions of fentanyl and buprenorphine. The significance of receptor binding","volume":"57","author":"Boas","year":"1985","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.mayocp.2019.10.007_bib6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0893-133X(00)00110-X","article-title":"Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study","volume":"23","author":"Zubieta","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.mayocp.2019.10.007_bib7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5055\/jom.2007.0018","article-title":"Use and misuse of buprenorphine in the management of opioid addiction","volume":"3","author":"Cicero","year":"2007","journal-title":"J\u00a0Opioid Manag"},{"issue":"3","key":"10.1016\/j.mayocp.2019.10.007_bib8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/ACO.0000000000000052","article-title":"The perioperative management of patients maintained on medications used to manage opioid addiction","volume":"27","author":"Bryson","year":"2014","journal-title":"Curr Opin Anaesthesiol"},{"issue":"Pt 7","key":"10.1016\/j.mayocp.2019.10.007_bib9","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/brain\/awq138","article-title":"Alterations in brain structure and functional connectivity in prescription opioid-dependent patients","volume":"133","author":"Upadhyay","year":"2010","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.mayocp.2019.10.007_bib10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.neuroscience.2010.07.033","article-title":"Acute effects of sublingual buprenorphine on brain responses to heroin-related cues in early-abstinent heroin addicts: an uncontrolled trial","volume":"170","author":"Mei","year":"2010","journal-title":"Neuroscience"},{"issue":"250","key":"10.1016\/j.mayocp.2019.10.007_bib11","article-title":"Perioperative pain management for patients on chronic buprenorphine: a case report","volume":"3","author":"Chern","year":"2013","journal-title":"J\u00a0Anesth Clin Res"},{"issue":"6","key":"10.1016\/j.mayocp.2019.10.007_bib12","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/ALN.0000000000001633","article-title":"To stop or not, that is the question: acute pain management for the patient on chronic buprenorphine","volume":"126","author":"Anderson","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.mayocp.2019.10.007_bib13","doi-asserted-by":"crossref","first-page":"j3221","DOI":"10.1136\/bmj.j3221","article-title":"Advances in the diagnosis and management of neck pain","volume":"358","author":"Cohen","year":"2017","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.mayocp.2019.10.007_bib14","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.mayocp.2015.10.009","article-title":"Evaluation and treatment of low back pain: a clinically focused review for primary care specialists","volume":"90","author":"Hooten","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"2S","key":"10.1016\/j.mayocp.2019.10.007_bib15","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.36076\/ppj.2017.s109","article-title":"Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 1","volume":"20","author":"Kaye","year":"2017","journal-title":"Pain Physician"},{"key":"10.1016\/j.mayocp.2019.10.007_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2014.12.011","article-title":"Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes","volume":"52","author":"Bentzley","year":"2015","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.mayocp.2019.10.007_bib17","series-title":"Bunavail (buprenorphine and naloxone) [package insert]","year":"2014"},{"key":"10.1016\/j.mayocp.2019.10.007_bib18","series-title":"Belbuca (buprenorphine) [package insert]","year":"2018"},{"issue":"2","key":"10.1016\/j.mayocp.2019.10.007_bib19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.clinthera.2015.12.016","article-title":"Evaluation of the pharmacokinetics of single- and multiple-dose buprenorphine buccal film in healthy volunteers","volume":"38","author":"Bai","year":"2016","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.mayocp.2019.10.007_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jpainsymman.2004.07.005","article-title":"Buprenorphine: considerations for pain management","volume":"29","author":"Johnson","year":"2005","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.mayocp.2019.10.007_bib21","series-title":"Probuphine (buprenorphine) [package insert]","year":"2018"},{"key":"10.1016\/j.mayocp.2019.10.007_bib22","unstructured":"Buprenex (buprenorphine) [package insert]. Richmond,VA: Reckitt Benckiser Pharmaceuticals Inc, Revised 11\/2017."},{"key":"10.1016\/j.mayocp.2019.10.007_bib23","unstructured":"Sublocade (buprenorphine and naloxone) [package insert]. North Chesterfield, VA: Indivior UK Limited; Revised: 4\/2019."},{"key":"10.1016\/j.mayocp.2019.10.007_bib24","unstructured":"Zubsolv (buprenorphine and naloxone) [package insert]. Morristown, NJ: Orexo US, Inc; Revised: 2\/2018."},{"key":"10.1016\/j.mayocp.2019.10.007_bib25","unstructured":"Suboxone (buprenorphine and naloxone) [package insert]. North Chesterfield, VA: Indivior UK Limited; Revised: 2\/2018."},{"key":"10.1016\/j.mayocp.2019.10.007_bib26","series-title":"Butrans (buprenorphine) [package insert]","year":"2014"},{"issue":"5","key":"10.1016\/j.mayocp.2019.10.007_bib27","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/ALN.0000000000000170","article-title":"Buprenorphine-naloxone therapy in pain management","volume":"120","author":"Chen","year":"2014","journal-title":"Anesthesiology"},{"issue":"12","key":"10.1016\/j.mayocp.2019.10.007_bib28","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40265-018-0953-z","article-title":"Treating chronic pain: an overview of clinical studies centered on the buprenorphine option","volume":"78","author":"Davis","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.mayocp.2019.10.007_bib29","unstructured":"Fudin J. A Brief Review of Buprenorphine Products. Pharmacy Times website, https:\/\/www.pharmacytimes.com\/contributor\/jeffrey-fudin\/2016\/03\/a-brief-review-of-buprenorphine-products. Published March 22, 2016. Accessed July 1, 2019."},{"issue":"9","key":"10.1016\/j.mayocp.2019.10.007_bib30","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s12630-014-0193-y","article-title":"Perioperative management of a patient undergoing Clagett window closure stabilized on Suboxone(R) for chronic pain: a case report","volume":"61","author":"Huang","year":"2014","journal-title":"Can J Anaesth"},{"issue":"2","key":"10.1016\/j.mayocp.2019.10.007_bib31","doi-asserted-by":"crossref","first-page":"E261","DOI":"10.36076\/ppj\/2015.18.E261","article-title":"Effect of buprenorphine on total intravenous anesthetic requirements during spine surgery","volume":"18","author":"Khelemsky","year":"2015","journal-title":"Pain Physician"},{"key":"10.1016\/j.mayocp.2019.10.007_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/rapm-2018-100018","article-title":"Implications of uninterrupted preoperative transdermal buprenorphine use on postoperative pain management","author":"Martin","year":"2019","journal-title":"Reg Anesth Pain Med"},{"issue":"8","key":"10.1016\/j.mayocp.2019.10.007_bib33","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/pme.12135","article-title":"Acute pain control challenges with buprenorphine\/naloxone therapy in a patient with compartment syndrome secondary to McArdle's disease: a case report and review","volume":"14","author":"McCormick","year":"2013","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.mayocp.2019.10.007_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-144-2-200601170-00010","article-title":"Acute pain management for patients receiving maintenance methadone or buprenorphine therapy","volume":"144","author":"Alford","year":"2006","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.mayocp.2019.10.007_bib35","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MJT.0b013e3181be0804","article-title":"Effectiveness of full agonist opioids in patients stabilized on buprenorphine undergoing major surgery: a case series","volume":"17","author":"Kornfeld","year":"2010","journal-title":"Am J Ther"},{"issue":"2","key":"10.1016\/j.mayocp.2019.10.007_bib36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/0310057X1304100212","article-title":"Pain relief and opioid requirements in the first 24 hours after surgery in patients taking buprenorphine and methadone opioid substitution therapy","volume":"41","author":"Macintyre","year":"2013","journal-title":"Anaesth Intensive Care"},{"issue":"2","key":"10.1016\/j.mayocp.2019.10.007_bib37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1213\/ANE.0000000000003477","article-title":"Opioid use disorders: perioperative management of a special population","volume":"127","author":"Ward","year":"2018","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.mayocp.2019.10.007_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/pm\/pny019","article-title":"Patients maintained on buprenorphine for opioid use disorder should continue buprenorphine through the perioperative period","volume":"20","author":"Lembke","year":"2019","journal-title":"Pain Med"},{"issue":"3","key":"10.1016\/j.mayocp.2019.10.007_bib39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.anclin.2018.04.002","article-title":"Perioperative considerations for the patient with opioid use disorder on buprenorphine, methadone, or naltrexone maintenance therapy","volume":"36","author":"Harrison","year":"2018","journal-title":"Anesthesiol Clin"},{"issue":"6","key":"10.1016\/j.mayocp.2019.10.007_bib40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40263-019-00637-z","article-title":"Buprenorphine treatment for opioid use disorder: an overview","volume":"33","author":"Shulman","year":"2019","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.mayocp.2019.10.007_bib41","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.npp.1300251","article-title":"Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers","volume":"28","author":"Greenwald","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.mayocp.2019.10.007_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0376-8716(80)90455-X","article-title":"A\u00a0study of hospitalized surgical patients on methadone maintenance","volume":"6","author":"Kantor","year":"1980","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.mayocp.2019.10.007_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0885-3924(00)00252-9","article-title":"Methadone analgesia in cancer pain patients on chronic methadone maintenance therapy","volume":"21","author":"Manfredi","year":"2001","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"1","key":"10.1016\/j.mayocp.2019.10.007_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/bja\/56.1.69","article-title":"Drug absorption by sublingual and rectal routes","volume":"56","author":"De Boer","year":"1984","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.mayocp.2019.10.007_bib45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/11208360-000000000-00000","article-title":"Buprenorphine 5,10 and 20 mcg\/h transdermal patch: a guide to its use in chronic non-malignant pain","volume":"26","author":"Plosker","year":"2012","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.mayocp.2019.10.007_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/009127009703700106","article-title":"Bioavailability of sublingual buprenorphine","volume":"37","author":"Mendelson","year":"1997","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.10.007_bib47","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1213\/ANE.0000000000002498","article-title":"Case series of successful postoperative pain management in buprenorphine maintenance therapy patients","volume":"125","author":"Leighton","year":"2017","journal-title":"Anesth Analg"},{"issue":"9","key":"10.1016\/j.mayocp.2019.10.007_bib48","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejpain.2010.03.002","article-title":"Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy","volume":"14","author":"Meyer","year":"2010","journal-title":"Eur J Pain"},{"issue":"3","key":"10.1016\/j.mayocp.2019.10.007_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/00952990902825413","article-title":"Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy","volume":"35","author":"Jones","year":"2009","journal-title":"Am J Drug Alcohol Abuse"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619308705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619308705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:33:10Z","timestamp":1758418390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619619308705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0025619619308705"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.10.007","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Practical Approach for the Management of the Mixed Opioid Agonist-Antagonist Buprenorphine During Acute Pain and Surgery","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}